Make your money go further for just 25p per day

Venture Capital Play | Brain Health Contracts

14/06/2021 · Cambridge Cognition (COG)  · Draper Esprit PLC (GROW) 

AIM UK Venture Capital

Neroscience image

A venture capital group covered here is raising new funds to take advantage of the buoyant market for rapidly growing technology companies in Europe. Elsewhere, a developer of digital solutions to assess brain health has secured more significant contracts. Read on here for more about these exciting investment opportunities.


Draper Esprit: looking good and loading up

Draper Esprit (LON: GROW, Euronext Growth: GRW), the AIM listed venture capital group investing in high growth digital technology businesses, announced excellent full year results and news of an equity raise.

Draper Esprit was a relatively unusual investing company for AIM when it listed on London’s growth market in June 2016 at a share price of 300p and market capitalisation of only £122m. The shares have climbed…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login


Previous article Next article

DON'T MISS OUT!

Get top investment ideas to help safeguard and grow your wealth.

Invaluable insight from the exciting world of smaller companies.

REGISTER FREE

DON'T MISS OUT ON OUR PREMIUM CONTENT

Become a champion investor for just £90 a year. Benefit from our high performing portfolios:

START FREE TRIAL

More on Cambridge Cognition

Challenging outlooks | Reassuringly boring | Hidden value

07/11/2024 · Company Insights

News covered here includes our assessment of two small caps facing challenging markets. Elsewhere, a fast…


Departure of CEO concerns the market

13/09/2024 · Company Insights

This developer of digital solutions to assess brain health saw its shares tumble at the beginning of…


More on Draper Esprit PLC

Venture Capital Play | Brain Health Contracts

14/06/2021 · Company Insights

A venture capital group covered here is raising new funds to take advantage of the buoyant…


Investing success and new assays

02/02/2021 · Company Insights

After a volatile start to 2021, the share price of last year’s top AIM performer received…


More Company Insights

Elderly challenges | Demotion | Australian boost

21/11/2024 · Churchill China · CVS Group · Renold · Tracsis

Bonkers Bargains: poised to recover with a new CEO

20/11/2024 · James Cropper

Improving returns | Questionable business models

Sign-up to our free email updates

SIGN UP